ATNM

Actinium Pharmaceuticals Stock Price

0.3559
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
0.3559
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Actinium Pharmaceuticals Inc ATNM AMEX Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.0419 13.34% 0.3559 0.319 0.40 0.3195 0.314 20:00:00
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
19,537 19,902,051 $ 0.3573063 $ 7,111,128 24,488,662 0.1506 - 0.6488
Last Trade Time Type Quantity Stock Price Currency
20:00:00 28,011 $ 0.3559 USD

Actinium Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 140.64M 395.15M 394.89M $ - $ - -0.15 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
2.65M $ - 0.00% - -

more financials information »

Actinium Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ATNM Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.36350.400.30770.336157910,631,078-0.0076-2.09%
1 Month0.330.64880.28050.410163628,091,2250.02597.85%
3 Months0.19420.64880.15060.335614215,314,5210.161783.26%
6 Months0.240.64880.15060.32102258,864,4030.115948.29%
1 Year0.2550.64880.15060.31118215,271,1750.100939.57%
3 Years1.141.160.15060.37844442,476,082-0.7841-68.78%
5 Years2.583.500.15060.56011581,701,147-2.22-86.21%

Actinium Pharmaceuticals Description

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells safely and effectively. Its most advanced products are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.


Your Recent History
AMEX
ATNM
Actinium P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.